Hattori Koichi, Ishihara Makoto, Heissig Beate
University of Tokyo, Institute of Medical Science, Laboratory of Stem Cell Regulation.
Clin Calcium. 2008 Apr;18(4):480-7.
Bone marrow-derived cells, which are recruited to peripheral tissues, have been shown to play a major role as angiogenic factor supplier. Moreover, bone marrow-derived "hemangiocytes" through graded chemokines production, can function as the molecular hub for hematopoietic cytokine-induced neovascularization. Current focus on cancer metastasis has centered on the intrinsic factors regulating the cell autonomous homing of the tumor cells to the metastatic site : Bone marrow-derived cells expressing vascular endothelial growth factor receptor 1 can be mobilized into the circulation due to growth factors released by the primary tumor. These cells cluster at distant sites, "the premetastatic niche" , where they set up a microenvironment ideal for tumor cells to seed, thereby completing the metastatic spread. Focus on the early cellular and molecular events in cancer infiltration, metastasis and proliferation will likely lead to new approaches to detect and prevent metastasis at its earliest inception.
骨髓来源的细胞会被募集到外周组织,已被证明作为血管生成因子供应者发挥主要作用。此外,骨髓来源的“血管生成细胞”通过分级产生趋化因子,可作为造血细胞因子诱导的新血管形成的分子枢纽。目前对癌症转移的关注集中在调节肿瘤细胞自主归巢至转移部位的内在因素上:由于原发肿瘤释放的生长因子,表达血管内皮生长因子受体1的骨髓来源细胞可被动员进入循环。这些细胞聚集在远处部位,即“前转移生态位”,在那里它们建立了一个适合肿瘤细胞着床的微环境,从而完成转移扩散。关注癌症浸润、转移和增殖过程中的早期细胞和分子事件,可能会带来在转移最早发生时进行检测和预防的新方法。